A single-cell, long-read, isoform-resolved case-control study of FTD reveals cell-type-specific and broad splicing dysregulation in human brain.

TitleA single-cell, long-read, isoform-resolved case-control study of FTD reveals cell-type-specific and broad splicing dysregulation in human brain.
Publication TypeJournal Article
Year of Publication2025
AuthorsBelchikov N, Hu W, Fan L, Joglekar A, He Y, Foord C, Jarroux J, Hsu J, Pollard S, Amin S, Prjibelski AD, Gong S, Zhang S, Giannelli R, Seelaar H, Tomescu AI, M Ross E, Li ANana, Grinberg LT, Spina S, Miller BL, Cooper-Knock J, Snyder MP, Seeley WW, Rao-Ruiz P, Spijker S, Smit AB, Clelland CD, Gan L, Tilgner HU
JournalCell Rep
Volume44
Issue9
Pagination116198
Date Published2025 Sep 23
ISSN2211-1247
KeywordsBrain, Case-Control Studies, Exons, Female, Frontotemporal Dementia, Humans, Male, Middle Aged, Neurons, Progranulins, Protein Isoforms, RNA Splicing, Single-Cell Analysis
Abstract

Progranulin-deficient frontotemporal dementia (GRN-FTD) is a major cause of familial FTD with TAR DNA-binding protein 43 (TDP-43) pathology, which is linked to exon dysregulation. However, little is known about this dysregulation in glial and neuronal cells. Here, using splice-junction-covering enrichment probes, we introduce single-nuclei long-read RNA sequencing 2 (SnISOr-Seq2), targeting 3,630 high-interest genes without loss of precision, and complete the first single-cell, long-read-resolved case-control study for neurodegeneration. Exons affected by FTD-associated skipping are shorter than those whose inclusion is increased. Up to 30% of cell-(sub)type-specific splicing dysregulation is masked by other cell types or cortical layers. Surprisingly, strong splicing dysregulation events can occur in select but not all cell types. In some cases, a cell type switches in FTD to the splicing pattern of a different cell type. In addition, in separate GRN-FTD samples, the more FTD-prone frontal cortex exhibits more FTD-associated splicing patterns than the occipital cortex. Our methodologies are widely applicable to brain and other diseases.

DOI10.1016/j.celrep.2025.116198
Alternate JournalCell Rep
PubMed ID40913764
PubMed Central IDPMC12558363
Grant ListP50 AG023501 / AG / NIA NIH HHS / United States
R35 GM152101 / GM / NIGMS NIH HHS / United States
U54 NS100717 / NS / NINDS NIH HHS / United States
U01 DA053625 / DA / NIDA NIH HHS / United States
R01 AG074541 / AG / NIA NIH HHS / United States
T32 DA039080 / DA / NIDA NIH HHS / United States
RF1 MH121267 / MH / NIMH NIH HHS / United States
P01 AG019724 / AG / NIA NIH HHS / United States
R01 AG054214 / AG / NIA NIH HHS / United States
P30 AG062422 / AG / NIA NIH HHS / United States
T32 GM132083 / GM / NIGMS NIH HHS / United States
R01 AG072758 / AG / NIA NIH HHS / United States
R01 AG079291 / AG / NIA NIH HHS / United States